Optipharm Co (XKRX:153710) 3-Year Revenue Growth Rate : 9.40% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Optipharm Co 3-Year Revenue Growth Rate?

Optipharm Co's Revenue per Share for the three months ended in Dec. 2023 was ₩343.11.

During the past 12 months, Optipharm Co's average Revenue per Share Growth Rate was 8.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 2.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was -19.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Optipharm Co was 9.40% per year. The lowest was -59.00% per year. And the median was -6.40% per year.

Competitive Comparison of Optipharm Co's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Optipharm Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optipharm Co's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optipharm Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Optipharm Co's 3-Year Revenue Growth Rate falls into.

Optipharm Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Optipharm Co (XKRX:153710) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Optipharm Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Optipharm Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Optipharm Co (XKRX:153710) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

6, 63 Osong, Hwaseong-eup, Heungduk-gu, Chungcheongbuk-do, Cheongju, KOR

Website

http://www.optipharm.co.kr

Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.

Optipharm Co (XKRX:153710) Headlines

No Headlines